Concepedia

Rituximab-based Therapy

Rituximab-Based Therapy is a therapeutic regimen in oncology that belongs to the class of targeted monoclonal antibody treatments and is specifically distinguished by its use of rituximab, a chimeric anti-CD20 antibody, to selectively deplete B-cells in the management of Central Nervous System Lymphoma.

5.7K

Publications

430.5K

Citations

30.3K

Authors

5.1K

Institutions

Publications per year

2017–2026

1.6K

Parents

Publications

5.7K

CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

Bertrand Coiffier, Éric Lepage, Josette Brière et al. · New England Journal of Medicine · 2002 · 5.6K citations · Full text

, , +9

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

Peter McLaughlin, A.J. Grillo-López, Brian K. Link et al. · Journal of Clinical Oncology · 1998 · 2.8K citations

, , +17

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

John H. Stone, Peter A. Merkel, Robert Spiera et al. · New England Journal of Medicine · 2010 · 2.7K citations · Full text

, , +17

Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis

Jonathan Edwards, L Szczepański, Jacek Szechiński et al. · New England Journal of Medicine · 2004 · 2.6K citations · Full text

, , +17

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

Stephen L. Hauser, Emmanuelle Waubant, Douglas L. Arnold et al. · New England Journal of Medicine · 2008 · 2.4K citations · Full text

, , +15

1–5 of 5.7K

Authors

30.3K

  1. GS
    Gilles Salles

    Hospices Civils de Lyon, France

    112 publications · 19.5K citations

    57

    h-index

  2. MH
    Michael Hallek

    University of Cologne, Germany

    82 publications · 12K citations

    43

    h-index

  3. CH
    Corinne Haïoun

    Assistance Publique – Hôpitaux de Paris, France

    67 publications · 8.1K citations

    43

    h-index

  4. HT
    Hervé Tilly

    Centre Henri Becquerel

    69 publications · 16.8K citations

    42

    h-index

  5. FM
    Franck Morschhauser

    Centre Hospitalier Universitaire de Lille, France

    84 publications · 9.7K citations

    41

    h-index

1–5 of 30.3K

Institutions

5.1K

  1. The University of Texas MD Anderson Cancer Center

    Houston, United States

    86 h-index

    2K publications

    223.7K citations

  2. Inserm

    Paris, France

    76 h-index

    965 publications

    128K citations

  3. Assistance Publique – Hôpitaux de Paris

    Paris, France

    75 h-index

    863 publications

    111.8K citations

  4. Dana-Farber Cancer Institute

    Boston, United States

    67 h-index

    679 publications

    74.6K citations

  5. Université Paris Cité

    Paris, France

    66 h-index

    550 publications

    76K citations

  6. Memorial Sloan Kettering Cancer Center

    New York, United States

    66 h-index

    590 publications

    116.1K citations

  7. University College London

    London, United Kingdom

    63 h-index

    573 publications

    95.2K citations

  8. Cornell University

    Ithaca, United States

    63 h-index

    548 publications

    95.4K citations

1–8 of 5.1K

Venues

  1. Blood

    764 publications · 66.8K citations

    140

    h-index

  2. Journal of Clinical Oncology

    320 publications · 57.5K citations

    132

    h-index

  3. PubMed

    Repository · 246 publications · 12.6K citations

    61

    h-index

  4. British Journal of Haematology

    BJH · 195 publications · 10.7K citations

    57

    h-index

  5. Arthritis & Rheumatism

    58 publications · 18.7K citations

    53

    h-index

1–5